Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now includes a Locations section with Florida as a site, and the previous 'Florida Locations' entry and the HHS Vulnerability Disclosure footer link were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe site revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved a general site-wide notice about government funding and operating status; this change does not affect the study details, eligibility criteria, or trial data.SummaryDifference0.4%

- Check60 days agoChange DetectedThe two screenshots show the same Study Details page (NCT03430791) with identical sections such as Brief Summary, Eligibility, Interventions, and Study Dates; no additions or deletions detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor addition: a prominent operating-status notice for users and a v3.2.0 release tag replaces the prior v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.